SLC5A6

Sodium-dependent multivitamin transporter · Q9Y289 · SLC5A6 on Sugi Atlas →

0 patent compounds predicted against SLC5A6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC5A6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Use of Empagliflozin to Treat Prediabetes PHASE4ACTIVE_NOT_RECRUITING
Dapagliflozin Effect on Erythropoiesis and Physical Fitness PHASE4WITHDRAWN
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases PHASE2/PHASE3WITHDRAWN
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH PHASE3COMPLETED
Magnesium Supplementation in People With XMEN Syndrome PHASE1/PHASE2COMPLETED
Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I EARLY_PHASE1COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Oxalate and Citrate in Humans - Response to Citrate nanRECRUITING
Oxalate and Citrate nanRECRUITING
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital nanUNKNOWN
Metabolic Availability of Lysine From Barley in Young Adult Men nanNOT_YET_RECRUITING
Mechanism of Decreased Iron Absorption in Obesity: Controlling Adiposity-related Inflammation nanCOMPLETED
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS nanNOT_YET_RECRUITING
Sodium Transport: Genetics and Hypertension nanCOMPLETED
Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients nanUNKNOWN
Individualized Antiretroviral Therapy nanCOMPLETED
Identification and Characterization of Monogenic Diabetes nanCOMPLETED
The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD) nanUNKNOWN
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
Genetic Epidemiology of Blood Pressure Intervention nanCOMPLETED
Lithium Countertransport and Blood Pressure In CARDIA and TOMHS nanCOMPLETED
Acceptability and Nutritional Impact of Double-fortified Salt Containing Iodine and Folic Acid - Phase 1 nanCOMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes nanCOMPLETED
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome nanENROLLING_BY_INVITATION
Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement nanCOMPLETED
Clinical Utility of Breath Tests in GI nanCOMPLETED
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SLC5A6 binder may also engage these)

ProteinNameSimilarity
Q9XT77 1.000 Q9XT77 →
Q5U4D8 1.000 Q5U4D8 →
O70247 1.000 O70247 →
Q9NS82 0.975 Q9NS82 →
P63116 0.967 P63116 →
P63115 0.963 P63115 →
Q8K415 0.958 Q8K415 →
Q8BHK3 0.955 Q8BHK3 →
Q8N695 0.953 Q8N695 →
Q7SYH5 0.951 Q7SYH5 →
Q8BYF6 0.950 Q8BYF6 →
Q9N1Q4 0.949 Q9N1Q4 →
Q96BD0 0.949 Q96BD0 →
Q9WVR6 0.949 Q9WVR6 →
Q2YDU8 0.946 Q2YDU8 →
Q6ZMD2 0.946 Q6ZMD2 →
Q5BL81 0.945 Q5BL81 →
Q8R0G7 0.945 Q8R0G7 →
Q9QXW9 0.945 Q9QXW9 →
Q495N2 0.945 Q495N2 →
Q8K078 0.944 Q8K078 →
Q99N01 0.943 Q99N01 →
Q9UHI5 0.942 Q9UHI5 →
Q5RAE3 0.942 Q5RAE3 →
Q9D232 0.941 Q9D232 →
Q8K4D3 0.940 Q8K4D3 →
Q9R154 0.940 Q9R154 →
Q495M3 0.940 Q495M3 →
Q9H2V7 0.939 Q9H2V7 →
Q08DX7 0.938 Q08DX7 →